Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

Alemtuzumab

1

II.b ARDS - Acute lung injury

1
Last update : 18/05/2012
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist

Publications

Alemtuzumab-induced lung injury in multiple sclerosis: Learning from adversity in three patients.
Multiple sclerosis and related disorders 2020 Jan;37;101450 2020 Jan
Acute respiratory distress syndrome following alemtuzumab therapy for relapsing multiple sclerosis.
Multiple sclerosis and related disorders 2017 May;14;1-3 2017 May
Pulmonary toxicities from targeted therapies: a review.
Targeted oncology 2011 Dec;6;235-43 2011 Dec
A fatal case of alemtuzumab-associated interstitial pneumonitis.
American journal of therapeutics 2008;15;82-4 2008

Powered by

  • ^
  • Contact
  • Cookies
  • About

The Pneumotox website uses cookies. By accessing or using our website, you consent to the collection, use and disclosure of the garnered information in accordance with our privacy policy.

Learn more about cookies